CoChat
Sign Up
Cited by 225

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis

Gisondi, Paolo, Targher, Giovanni, Zoppini, Giacomo, Girolomoni, Giampiero·2009·Journal of Hepatology
DOI 10.1016/j.jhep.2009.04.020
Open this paper in CoChat — free account

Abstract

Background/aims Non-alcoholic fatty liver disease (NAFLD) and chronic plaque psoriasis are both associated with metabolic syndrome and increased risk of incident cardiovascular disease. We assessed the frequency and characteristics of NAFLD in patients with chronic plaque psoriasis. Methods One hundred and thirty consecutive patients with chronic plaque psoriasis and 260 apparently healthy controls matched for age, sex and body mass index were enrolled. NAFLD was diagnosed by abdominal ultrasound after excluding other secondary causes of chronic liver disease. Results The frequency of NAFLD was remarkably greater in psoriasis patients than in controls (47% vs. 28%; p Conclusions NAFLD is frequent in patients with chronic plaque psoriasis - affecting up to nearly half of these patients - and is strongly associated with psoriasis severity. Early recognition of NAFLD by radiological imaging tests in this group of patients is warranted.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2009.04.020

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 3 references

Research works printed but not linked: 37

  1. Griffiths, 2007, Pathogenesis and clinical features of psoriasis, Lancet, 370, 263, 10.1016/S0140-6736(07)61128-3 · DOI
  2. Sommer, 2006, Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis, Arch Dermatol Res, 298, 321, 10.1007/s00403-006-0703-z · DOI
  3. Gisondi, 2007, Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study, Br J Dermatol, 157, 68, 10.1111/j.1365-2133.2007.07986.x · DOI
  4. Ucak, 2006, Comparison of various insulin sensitivity indices in psoriatic patients and their relationship with type of psoriasis, J Eur Acad Dermatol Venereol, 20, 517, 10.1111/j.1468-3083.2006.01499.x · DOI
  5. Boehncke, 2007, Psoriasis patients show signs of insulin resistance, Br J Dermatol, 157, 1249, 10.1111/j.1365-2133.2007.08190.x · DOI
  6. Adams, 2005, Nonalcoholic fatty liver disease, CMAJ, 172, 899, 10.1503/cmaj.045232 · DOI
  7. de Alwis, 2008, Non-alcoholic fatty liver disease: the mist gradually clears, J Hepatol, 48, S104, 10.1016/j.jhep.2008.01.009 · DOI
  8. Marchesini, 2005, Nonalcoholic fatty liver disease and the metabolic syndrome, Curr Opin Lipidol, 16, 421, 10.1097/01.mol.0000174153.53683.f2 · DOI
  9. Kotronen, 2008, Fatty liver: a novel component of the metabolic syndrome, Arterioscler Thromb Vasc Biol, 28, 27, 10.1161/ATVBAHA.107.147538 · DOI
  10. Lonardo, 2001, Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI.ST.E.N.A. study, Dig Liver Dis, 33, 86, 10.1016/S1590-8658(01)80144-4 · DOI
  11. Targher, 2007, Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients, Diabetes Care, 30, 1212, 10.2337/dc06-2247 · DOI
  12. Grundy, 2005, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation, 112, 2735, 10.1161/CIRCULATIONAHA.105.169404 · DOI · Paper page
  13. Taylor, 2006, Classification criteria for psoriatic arthritis: development of new criteria from a large international study, Arthritis Rheum, 54, 2665, 10.1002/art.21972 · DOI
  14. Loria, 2007, Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question, Nutr Metab Cardiovasc Dis, 17, 684, 10.1016/j.numecd.2007.01.007 · DOI
  15. Targher, 2008, Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?, Diabetologia, 51, 1947, 10.1007/s00125-008-1135-4 · DOI
  16. Albanesi, 2009, Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment, J Exp Med, 206, 249, 10.1084/jem.20080129 · DOI
  17. Mallbris, 2004, Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients, Eur J Epidemiol, 19, 225, 10.1023/B:EJEP.0000020447.59150.f9 · DOI
  18. Kaye, 2008, Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis, Br J Dermatol, 159, 895, 10.1111/j.1365-2133.2008.08707.x · DOI
  19. Wakkee, 2007, Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients, Atherosclerosis, 190, 1, 10.1016/j.atherosclerosis.2006.07.011 · DOI
  20. Neimann, 2006, Prevalence of cardiovascular risk factors in patients with psoriasis, J Am Acad Dermatol, 55, 829, 10.1016/j.jaad.2006.08.040 · DOI
  21. Gelfand, 2007, The risk of mortality in patients with psoriasis: results from a population-based study, Arch Dermatol, 143, 1493, 10.1001/archderm.143.12.1493 · DOI
  22. Malerba, 2006, Plasma homocysteine and folate levels in patients with chronic plaque psoriasis, Br J Dermatol, 155, 1165, 10.1111/j.1365-2133.2006.07503.x · DOI
  23. Sergeant, 2008, C-reactive protein in psoriasis, Br J Dermatol, 158, 417, 10.1111/j.1365-2133.2007.08334.x · DOI
  24. Nickoloff, 2007, The cytokine and chemokine network in psoriasis, Clin Dermatol, 25, 568, 10.1016/j.clindermatol.2007.08.011 · DOI
  25. Tamagawa-Mineoka, 2008, Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of thromboglobulin and platelet factor 4, Allergol Int, 57, 391, 10.2332/allergolint.O-08-537 · DOI
  26. Targher, 2006, Associations between plasma adiponectin concentrations and liver histology in patients with non-alcoholic fatty liver disease, Clin Endocrinol, 64, 679, 10.1111/j.1365-2265.2006.02527.x · DOI
  27. Targher, 2006, Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease, J Hepatol, 45, 879, 10.1016/j.jhep.2006.09.005 · DOI
  28. Haukeland, 2006, Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2, J Hepatol, 44, 1167, 10.1016/j.jhep.2006.02.011 · DOI
  29. Targher, 2008, NASH predicts plasma inflammatory biomarkers independently of visceral fat in men, Obesity (Silver Spring), 16, 1394, 10.1038/oby.2008.64 · DOI
  30. Abiru, 2006, Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis, Liver Int, 26, 39, 10.1111/j.1478-3231.2005.01191.x · DOI
  31. Chalasani, 2004, Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with non-alcoholic steatohepatitis, Am J Gastroenterol, 99, 1497, 10.1111/j.1572-0241.2004.30159.x · DOI · Paper page
  32. Wieckowska, 2008, Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis, Am J Gastroenterol, 103, 1372, 10.1111/j.1572-0241.2007.01774.x · DOI · Paper page
  33. Sun, 2009, Adiponectin, an unlocking adipocytokine, Cardiovasc Ther, 27, 59, 10.1111/j.1755-5922.2008.00069.x · DOI
  34. Takahashi, 2008, Plasma adiponectin and leptin levels in Japanese patients with psoriasis, Br J Dermatol, 159, 1207
  35. Ritchie, 2007, The link between abdominal obesity, metabolic syndrome and cardiovascular disease, Nutr Metab Cardiovasc Dis, 17, 319, 10.1016/j.numecd.2006.07.005 · DOI
  36. Kaur, 2008, Clear differences in adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis, Br J Dermatol, 159, 1364, 10.1111/j.1365-2133.2008.08759.x · DOI
  37. Rosenberg, 2007, Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment, J Hepatol, 46, 995, 10.1016/j.jhep.2007.01.024 · DOI · Paper page

Cited by

Sorted by citations

See all 225

Metadata

Authors
Gisondi, P., Targher, G., Zoppini, G., & Girolomoni, G.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2009-10
Volume
51
Issue
4
Pages
758-764
ISSN
0168-8278
DOI
10.1016/j.jhep.2009.04.020
Cited by
225
References
3
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. https://app.cochat.ai/papers/10.1016/j.jhep.2009.04.020
The paper
Gisondi, P., Targher, G., Zoppini, G., & Girolomoni, G. (2009). Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2009.04.020